Search research articles
Contact Us
Filters
Showing results (61-70 of 213) with videos related to
Page
of 22
Sort By:
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
Integrating computational chemistry and machine learning to predict KRAS mutation-induced resistance
Katarzyna Mizgalska, Konstancja Urbaniak, Denis J Imbody, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 27, 2010
Molecular origins of lung cancer: prospects for personalized prevention and therapy
Eric B Haura, D Ross Camidge, Karen Reckamp, et al.
Plos Computational Biology
|
March 30, 2023
Network models of protein phosphorylation, acetylation, and ubiquitination connect metabolic and cell signaling pathways in lung cancer
Karen E Ross, Guolin Zhang, Cuneyt Akcora, et al.
Cancer Research Communications
|
June 4, 2026
Targeting GSTZ1 sensitizes KRAS G12C-mutant lung cancer cells by overcoming glutathione and glycolysis pathway rewiring
Yi Liao, Xueli Li, Min Liu, et al.
Journal of Clinical Trials
|
June 24, 2015
Chemoprevention Trial Feasibility Using Botanicals in Exceptionally High Risk Populations for Lung Cancer
Nagi B Kumar, Gwendolyn P Quinn, Mark G Alexandrow, et al.
Journal of Integrated OMICS
|
October 1, 2013
Optimisation of Downscaled Tandem Affinity Purifications to Identify Core Protein Complexes
Eric B Haura, Roberto Sacco, Jiannong Li, et al.
The Journal of Biological Chemistry
|
October 13, 2012
Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions
Lu Chen, Dung-Tsa Chen, Courtney Kurtyka, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
April 12, 2022
Overcoming <i>KRAS</i>-Mutant Lung Cancer
Jia Luo, Jonathan Ostrem, Bruna Pellini, et al.
Redox Biology
|
February 3, 2020
Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone
Laura Torrente, Nicolas Prieto-Farigua, Aimee Falzone, et al.
Translational Cancer Research
|
August 29, 2019
Application of Bayesian predictive probability for interim futility analysis in single-arm phase II trial
Dung-Tsa Chen, Michael J Schell, William J Fulp, et al.
Page
of 22
Search research articles
Search
Showing results (61-70 of 213) with videos related to
Sort By:
Page
of 22
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
Integrating computational chemistry and machine learning to predict KRAS mutation-induced resistance
Katarzyna Mizgalska, Konstancja Urbaniak, Denis J Imbody, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 27, 2010
Molecular origins of lung cancer: prospects for personalized prevention and therapy
Eric B Haura, D Ross Camidge, Karen Reckamp, et al.
Plos Computational Biology
|
March 30, 2023
Network models of protein phosphorylation, acetylation, and ubiquitination connect metabolic and cell signaling pathways in lung cancer
Karen E Ross, Guolin Zhang, Cuneyt Akcora, et al.
Cancer Research Communications
|
June 4, 2026
Targeting GSTZ1 sensitizes KRAS G12C-mutant lung cancer cells by overcoming glutathione and glycolysis pathway rewiring
Yi Liao, Xueli Li, Min Liu, et al.
Journal of Clinical Trials
|
June 24, 2015
Chemoprevention Trial Feasibility Using Botanicals in Exceptionally High Risk Populations for Lung Cancer
Nagi B Kumar, Gwendolyn P Quinn, Mark G Alexandrow, et al.
Journal of Integrated OMICS
|
October 1, 2013
Optimisation of Downscaled Tandem Affinity Purifications to Identify Core Protein Complexes
Eric B Haura, Roberto Sacco, Jiannong Li, et al.
The Journal of Biological Chemistry
|
October 13, 2012
Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions
Lu Chen, Dung-Tsa Chen, Courtney Kurtyka, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
April 12, 2022
Overcoming <i>KRAS</i>-Mutant Lung Cancer
Jia Luo, Jonathan Ostrem, Bruna Pellini, et al.
Redox Biology
|
February 3, 2020
Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone
Laura Torrente, Nicolas Prieto-Farigua, Aimee Falzone, et al.
Translational Cancer Research
|
August 29, 2019
Application of Bayesian predictive probability for interim futility analysis in single-arm phase II trial
Dung-Tsa Chen, Michael J Schell, William J Fulp, et al.
Page
of 22